跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
OMVOH 300 MG CONCENTRADO PARA SOLUCION PARA PERFUSION
Approved
STANDARD
OMVOH 300 MG CONCENTRADO PARA SOLUCION PARA PERFUSION
Eli Lilly Nederland B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jun 27, 2023
Approval ID
32fb9ce2c6e94317
Company
Eli Lilly Nederland B.V.
Type
Standard
Approval Details
Approval Id
32fb9ce2c6e94317
Drug Cima Aemps Name
OMVOH 300 MG CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number
1231736001
Holder Company Name
Eli Lilly Nederland B.V.
Marketing Company Name
Lilly S.A.
Holder Company Detail Path
/organization/eli-lilly-nederland-bv
Marketing Company Detail Path
/organization/lilly-sa
Authorization Date
2023-06-27
Dosage Form
CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose
300 MG
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Eli Lilly Nederland B.V.
Company Detail Path
/organization/eli-lilly-nederland-bv
Company Information
Pharmaceutical Company Name
Eli Lilly Nederland BV
Country Name
Netherlands
Website
http://www.lilly.com/nl
Active Ingredients
MIRIKIZUMAB
300 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jun 27, 2023
Approval ID
32fb9ce2c6e94317
Type
Standard
Back to CIMA-AEMPS Approvals
OMVOH 300 MG CONCENTRADO PARA SOLUCION PARA PERFUSION - CIMA-AEMPS Drug Approval Details
